英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
abaesse查看　abaesse　在百度字典中的解释百度英翻中〔查看〕
abaesse查看　abaesse　在Google字典中的解释Google英翻中〔查看〕
abaesse查看　abaesse　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • PROVENGE® (sipuleucel-T)
    PROVENGE is personal PROVENGE is the first FDA-approved personalized immunotherapy for treatment of advanced prostate cancer It has been clinically proven to extend life for certain men with mCRPC As a personalized immunotherapy, PROVENGE works differently from other cancer treatments, such as chemotherapy or hormone therapy
  • Questions and Answers - Provenge | FDA
    PROVENGE (sipuleucel-T) is an autologous cellular immunotherapy designed to stimulate a patient’s own immune system against cancer
  • Why Provenge Failed Despite Its Scientific Breakthrough
    Sipuleucel-T, marketed as Provenge, was the first therapeutic cancer vaccine approved by the U S Food and Drug Administration (FDA) in 2010 Its approval for prostate cancer treatment represented a landmark scientific achievement, heralding a new era of immunotherapy and personalized medicine Despite this revolutionary status, Provenge failed commercially, leading to the financial collapse
  • Provenge for Prostate Cancer: Uses, Dosage Side Effects . . .
    Provenge (sipuleucel-T) is a personalized immunotherapy used to treat advanced prostate cancer Includes Provenge side effects, process, interactions and indications
  • Provenge Advanced Prostate Cancer Treatment - UCLA Health
    Provenge Therapy, Advanced Prostate Cancer Treatment Urologists at UCLA Urology are offering Provenge, a treatment option for advanced prostate cancer UCLA Urologists were collaborators on clinical trials that helped lead to the U S Food and Drug Administration (FDA) approval of Provenge in 2010, and have been treating patients with Provenge at the Clark Urology Center since 2003
  • Sipuleucel-T - Wikipedia
    Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP) [1][3][4] It is an autologous cellular immunotherapy
  • Immunotherapy for Prostate Cancer - American Cancer Society
    Immunotherapy is the use of medicines to stimulate a person’s own immune system to recognize and destroy cancer cells more effectively Certain types of immunotherapy can be used to treat prostate cancer Sipuleucel-T (Provenge) is a cancer vaccine Unlike traditional vaccines, which boost the
  • Sipuleucel-T — Grokipedia
    Sipuleucel-T, marketed as Provenge, is an autologous cellular immunotherapy designed to stimulate a patient's immune system to target prostate cancer cells expressing prostatic acid phosphatase (PAP),
  • Provenge: Cost, side effects, uses, how it works, and more
    Provenge (sipuleucel-T) is a prescription drug that treats prostate cancer in adult males Learn about cost, side effects, uses, how it works, and more
  • Prostate Cancer Immunotherapy | Dendreon
    PROVENGE ® (sipuleucel-T) PROVENGE ® (sipuleucel-T) has been available in the United States since 2010 It is the first and only FDA-approved immunotherapy for the treatment of advanced prostate cancer made from a patient’s own immune cells This groundbreaking treatment has been prescribed to nearly 40,000 men with advanced prostate cancer, helping many live longer For more information





中文字典-英文字典  2005-2009